Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jbono
    Junior Member
    • May 2013
    • 4

    Design of expt across multiple lanes

    Hi,

    I am performing an RNA-seq experiment to look at differential expression. The design is as follows:

    2 populations x 3 biological replicates x 3 food treatments = 18 samples total

    My interest is to make comparisons between food types within each population, and also to compare populations on the same food type. I was originally planning to use two HiSeq lanes, but am concerned about lane effects if I were to, for example, do one population on each lane (9 samples per lane)--any comparisons between populations would be confounded by possible lane effects. Unfortunately, I don't think I can multiplex more than 12 to a lane (according to the rep I am talking with), so I can't spread all 18 samples over two lanes. So, I am considering two options:

    1. Do 12 samples in one lane and 6 in the other. One lane would have 2 biological replicates from each population, and the other lane would have the other biological replicate from each population. At least this would be unbiased because pops/treatments are spread the same say across lanes. My concerns: is 12 to many in a lane to get appropriate coverage for each sample? Obviously depth will vary considerably between the samples in the two lanes--will this be difficult to deal with when I do the analysis or is this easily accounted for in normalization?

    2. Run three lanes, 6 in each lane. I don't see any problems with this except that I would like to avoid the extra cost with running another lane if at all possible.

    I'm looking for any guidance or other ideas more experienced people may have. Thanks!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    You just need the right kind of multiplexing method. You can do 96 per lane (or more).
    Last edited by GenoMax; 05-15-2013, 10:07 AM.

    Comment

    • jbono
      Junior Member
      • May 2013
      • 4

      #3
      Unfortunately, I am not building the libraries and the company I am working with apparently doesn't multiplex more than 12 according to the representative. I'll try sending him this, but I'm afraid I might be stuck with 12. Thanks for your suggestion!

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
        The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
        Whether you're exploring Kheloyaar for the first time or want to understand...
        Today, 09:27 PM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        Today, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        Yesterday, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:04 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:08 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...